Explicitly, we revealed a mechanism by which apigenin increases the availability of DR5 TRAIL receptor, while weakening the inhibitory effects of c-FLIPs and Hsp70 on the DISC, thereby overcoming the resistance of lung cancer cells to TRAIL-mediated apoptosis. Here, TNFSF10 is linked to lung carcinoma.